Pulmonary Fibrosis : A Current Theory on Pathogenesis

In this well-made animation video by Hurd Studios, find out more about pulmonary fibrosis, thoughts on how its mechanisms are triggered to develop the disease, potential associated factors, and how the disease behaves toward the lungs in different stages of development. Learn more about pulmonary fibrosis: https://bit.ly/PNewsToday…

In this video from Thorax (the youtube channel of Thorax journal), watch Professor Viswanathan (Nati) Natarajan, from the University of Illinois, Chicago, talk about idiopathic pulmonary fibrosis, a chronic and progressive lung disease for which the prognosis is poor and diagnosis is difficult to conduct. Prof. Viswanathan’s…

Early pulmonary rehabilitation is extremely important to idiopathic pulmonary fibrosis patients. Thorax shared this video in 2014, where Julia Bott, Respiratory Care Team, Surrey PCT, explains the importance of pulmonary rehabilitation and the impact it can have on patients. Learn more about…

The Lung Institute shared this inspirational video, where you can Joseph O’s pulmonary fibrosis story. In the early stages of dealing with the disease, Joseph had to be on oxygen all the time and he had trouble walking without being breathless.  Walking up the…

“This is not a story of death, it’s a story of life”. These are the words Travis Murphy, whose mother died unexpectedly from a brain aneurism, shares with us about his story. After the devastating death of his mom, Travis – along with his family – made the decision…

Researchers at the University of Southampton used an advanced, 3-D X-ray imaging technology for a first time on lung tissue samples from idiopathic pulmonary fibrosis (IPF) patients, gaining a better understanding of how the aggressive lung disease develops in the body. The study, “Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis” was published…

Thorax shared this video in 2014, where Lisa Spencer, a respiratory physician from Aintree Chest Centre, Aintree Hospital, Liverpool, discusses some of the possible issues of patient access to specialized idiopathic pulmonary fibrosis (IPF) centers and also the access to trial participation.